Doximity, Inc.

BOVESPA:D2OC34 Stock Report

Market Cap: R$59.3b

Doximity Future Growth

Future criteria checks 2/6

Doximity is forecast to grow earnings and revenue by 9.4% and 9.3% per annum respectively. EPS is expected to grow by 10.6% per annum. Return on equity is forecast to be 20.5% in 3 years.

Key information

9.4%

Earnings growth rate

10.6%

EPS growth rate

Healthcare Services earnings growth0%
Revenue growth rate9.3%
Future return on equity20.5%
Analyst coverage

Good

Last updated22 Nov 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

BOVESPA:D2OC34 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/202765520927329412
3/31/202659417925727017
3/31/202554016423123716
9/30/2024517174217224N/A
6/30/2024494161162168N/A
3/31/2024475148178184N/A
12/31/2023468138162167N/A
9/30/2023448123160165N/A
6/30/2023437119186192N/A
3/31/2023419113173180N/A
12/31/2022402119173180N/A
9/30/2022384141151159N/A
6/30/2022362148131138N/A
3/31/2022344133121127N/A
12/31/2021317107113117N/A
9/30/202127757110114N/A
6/30/202124330103107N/A
3/31/2021207227883N/A
12/31/2020177144853N/A
3/31/2020116112226N/A
3/31/20198611415N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: D2OC34's forecast earnings growth (9.4% per year) is below the savings rate (10.4%).

Earnings vs Market: D2OC34's earnings (9.4% per year) are forecast to grow slower than the BR market (12.5% per year).

High Growth Earnings: D2OC34's earnings are forecast to grow, but not significantly.

Revenue vs Market: D2OC34's revenue (9.3% per year) is forecast to grow faster than the BR market (7.4% per year).

High Growth Revenue: D2OC34's revenue (9.3% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: D2OC34's Return on Equity is forecast to be high in 3 years time (20.5%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y